A recent review confirms the safety and efficacy of biosimilar insulins, addressing concerns and promoting their adoption for ...

Background: Severe hypoglycaemia (SH) is one of the most feared complications of type 1 diabetes (T1DM) with a reported prevalence of nearly 40%. In randomized trials of Multiple Daily Injections ...

The study included 31,229 dementia-free adult United Kingdom Biobank participants aged 40 to 70 years. Exclusion criteria included chronic neurological disorders, insulin-dependent diabetes, and ...

AdventHealth researchers are seeking participants for a study that will attempt to identify people with type 1 diabetes early in their disease.

In 2022, there were around 828 million people aged 18 years and older with type 1 and type 2 diabetes worldwide, the study found. Among adults aged 30 years and older, 445 million, ...